Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials - Venkatraman, Navin; Tiono, Alfred B; Bowyer, Georgina; Bellamy, Duncan G; Stockdale, Lisa K; Powlson, Jonathan; Collins, Katharine A; Coulibaly, Sam; Datoo, Mehreen S; Silman, Daniel; Ouedraogo, Alphonse; Nébié, Issa; et al. (The lancet. Microbe, 2025)
Online verfügbar: 10. Januar 2025, Artikelversion: 3. März 2025